Blueprint Medicines Corporation (BPMC) vs Ultragenyx Pharmaceutical Inc. (RARE)
Detailed comparison between Blueprint Medicines Corporation, Ultragenyx Pharmaceutical Inc..Total Return (%)
Blueprint Medicines Corporation (BPMC)Ultragenyx Pharmaceutical Inc. (RARE)
Which stock do you think will perform better?
Blueprint Medicines Corporation
BPMC
Ultragenyx Pharmaceutical Inc.
RARE
Metric | Blueprint Medicines Corporation (BPMC) | Ultragenyx Pharmaceutical Inc. (RARE) |
---|---|---|
Current Price | $129.46 | $26.90 |
Change | 0.00 (0.00%) | -0.51 (-1.86%) |
Market Cap | $8.37B | $2.54B |
Trailing P/E | 0.00 | 0.00 |
Forward P/E | -137.72 | -5.26 |
Dividend Yield | 0.00% | 0.00% |
52-Week High | $129.55 | $60.37 |
52-Week Low | $73.04 | $26.46 |
Beta | 0.00 | 0.00 |
Earnings Per Share | $-2.51 | $-5.83 |
Processing data. Please try again later.
Average Return
Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
---|---|---|---|---|---|---|
BPMC | 0.98% | 15.63% | 12.60% | 65.06% | 308.26% | 308.26% |
RARE | -27.57% | -34.84% | -36.78% | -69.40% | -79.94% | -79.94% |